Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis

References

• Hua X, Wu J, Goldstein JL, Brown MS, Hobbs HH. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics 1995; 25:667 - 73; http://dx.doi.org/10.1016/0888-7543(95)80009-B; PMID: 7759101
   PubMed Web of Science ®Google Scholar
• Edwards PA, Tabor D, Kast HR, Venkateswaran A. Regulation of gene expression by SREBP and SCAP. Biochim Biophys Acta 2000; 1529:103 - 13; PMID: 11111080
   PubMed Web of Science ®Google Scholar
• Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 1994; 77:53 - 62; http://dx.doi.org/10.1016/0092-8674(94)90234-8; PMID: 8156598
   PubMed Web of Science ®Google Scholar
• Hua X, Yokoyama C, Wu J, Briggs MR, Brown MS, Goldstein JL, et al. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci USA 1993; 90:11603 - 7; http://dx.doi.org/10.1073/pnas.90.24.11603; PMID: 7903453
   PubMed Web of Science ®Google Scholar
• Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993; 75:187 - 97; PMID: 8402897
   PubMed Web of Science ®Google Scholar
• Briggs MR, Yokoyama C, Wang X, Brown MS, Goldstein JL. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J Biol Chem 1993; 268:14490 - 6; PMID: 8390995
   PubMed Web of Science ®Google Scholar
• Wang X, Briggs MR, Hua X, Yokoyama C, Goldstein JL, Brown MS. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization. J Biol Chem 1993; 268:14497 - 504; PMID: 8314806
   PubMed Web of Science ®Google Scholar
• Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 2001; 40:439 - 52; http://dx.doi.org/10.1016/S0163-7827(01)00010-8; PMID: 11591434
   PubMed Web of Science ®Google Scholar
• Horton JD, Shimomura I. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol 1999; 10:143 - 50; http://dx.doi.org/10.1097/00041433-199904000-00008; PMID: 10327282
   PubMed Web of Science ®Google Scholar
• Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006; 9:358 - 65; http://dx.doi.org/10.1097/01.mco.0000232894.28674.30; PMID: 16778563
   PubMed Web of Science ®Google Scholar
• Yang YA, Morin PJ, Han WF, Chen T, Bornman DM, Gabrielson EW, et al. Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Exp Cell Res 2003; 282:132 - 7; http://dx.doi.org/10.1016/S0014-4827(02)00023-X; PMID: 12531699
   PubMed Web of Science ®Google Scholar
• Ettinger SL, Sobel R, Whitmore TG, Akbari M, Bradley DR, Gleave ME, et al. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res 2004; 64:2212 - 21; http://dx.doi.org/10.1158/0008-5472.CAN-2148-2; PMID: 15026365
   PubMed Web of Science ®Google Scholar
• Yahagi N, Shimano H, Hasegawa K, Ohashi K, Matsuzaka T, Najima Y, et al. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer 2005; 41:1316 - 22; http://dx.doi.org/10.1016/j.ejca.2004.12.037; PMID: 15869874
   PubMed Web of Science ®Google Scholar
• Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 2011; 140:1071 - 83; http://dx.doi.org/10.1053/j.gastro.2010.12.006; PMID: 21147110
   PubMed Web of Science ®Google Scholar
• Yamashita T, Honda M, Takatori H, Nishino R, Minato H, Takamura H, et al. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol 2009; 50:100 - 10; http://dx.doi.org/10.1016/j.jhep.2008.07.036; PMID: 19008011
   PubMed Web of Science ®Google Scholar
• Li JN, Mahmoud MA, Han WF, Ripple M, Pizer ES. Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. Exp Cell Res 2000; 261:159 - 65; http://dx.doi.org/10.1006/excr.2000.5054; PMID: 11082286
   PubMed Web of Science ®Google Scholar
• Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY, et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res 2008; 68:1003 - 11; http://dx.doi.org/10.1158/0008-5472.CAN-07-2489; PMID: 18281474
   PubMed Web of Science ®Google Scholar
• Yoon S, Lee MY, Park SW, Moon JS, Koh YK, Ahn YH, et al. Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. J Biol Chem 2007; 282:26122 - 31; http://dx.doi.org/10.1074/jbc.M702854200; PMID: 17631500
   PubMed Web of Science ®Google Scholar
• Yang YA, Han WF, Morin PJ, Chrest FJ, Pizer ES. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp Cell Res 2002; 279:80 - 90; http://dx.doi.org/10.1006/excr.2002.5600; PMID: 12213216
   PubMed Web of Science ®Google Scholar
• Kim JB, Wright HM, Wright M, Spiegelman BM. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci USA 1998; 95:4333 - 7; http://dx.doi.org/10.1073/pnas.95.8.4333; PMID: 9539737
   PubMed Web of Science ®Google Scholar
• Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 1996; 10:1096 - 107; http://dx.doi.org/10.1101/gad.10.9.1096; PMID: 8654925
   PubMed Web of Science ®Google Scholar
• Lupu R, Menendez JA. Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?. Endocrinology 2006; 147:4056 - 66; http://dx.doi.org/10.1210/en.2006-0486; PMID: 16809439
   PubMed Web of Science ®Google Scholar
• Tsuji T, Yoshinaga M, Togami S, Douchi T, Nagata Y. Fatty acid synthase expression and clinicopathological findings in endometrial cancer. Acta Obstet Gynecol Scand 2004; 83:586 - 90; PMID: 15144342
   PubMed Web of Science ®Google Scholar
• Yin C, Qie S, Sang N. Carbon source metabolism and its regulation in cancer cells. Crit Rev Eukaryot Gene Expr 2012; 22:17 - 35; PMID: 22339657
   PubMed Web of Science ®Google Scholar
• Kim JB, Sarraf P, Wright M, Yao KM, Mueller E, Solanes G, et al. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest 1998; 101:1 - 9; http://dx.doi.org/10.1172/JCI1411; PMID: 9421459
   PubMed Web of Science ®Google Scholar
• Chen G, Liang G, Ou J, Goldstein JL, Brown MS. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci USA 2004; 101:11245 - 50; http://dx.doi.org/10.1073/pnas.0404297101; PMID: 15266058
   PubMed Web of Science ®Google Scholar
• Walker AK, Yang F, Jiang K, Ji JY, Watts JL, Purushotham A, et al. Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev 2010; 24:1403 - 17; http://dx.doi.org/10.1101/gad.1901210; PMID: 20595232
   PubMed Web of Science ®Google Scholar
• Eberhard Y, Gronda M, Hurren R, Datti A, MacLean N, Ketela T, et al. Inhibition of SREBP1 sensitizes cells to death ligands. Oncotarget 2011; 2:186 - 96; PMID: 21406729
   PubMed Web of Science ®Google Scholar
• Lao T, Chen S, Sang N. Two mutations impair the stability and function of ubiquitin-activating enzyme (E1). J Cell Physiol 2012; 227:1561 - 8; http://dx.doi.org/10.1002/jcp.22870; PMID: 21678405
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Kim JB, Graves RA, Spiegelman BM. ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 1993; 13:4753 - 9; PMID: 8336713
   PubMed Web of Science ®Google Scholar
• Migita T, Narita T, Nomura K, Miyagi E, Inazuka F, Matsuura M, et al. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res 2008; 68:8547 - 54; http://dx.doi.org/10.1158/0008-5472.CAN-08-1235; PMID: 18922930
   PubMed Web of Science ®Google Scholar
• Zu XY, Zhang QH, Liu JH, Cao RX, Zhong J, Yi GH, et al. ATP citrate lyase inhibitors as novel cancer therapeutic agents. Recent Pat Anticancer Drug Discov 2012; 7:154 - 67; http://dx.doi.org/10.2174/157489212799972954; PMID: 22339355
   PubMed Web of Science ®Google Scholar
• Luo DX, Tong DJ, Rajput S, Wang C, Liao DF, Cao D, et al. Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential. Recent Pat Anticancer Drug Discov 2012; 7:168 - 84; http://dx.doi.org/10.2174/157489212799972918; PMID: 22339356
   PubMed Web of Science ®Google Scholar
• Wang C, Rajput S, Watabe K, Liao DF, Cao D. Acetyl-CoA carboxylase-a as a novel target for cancer therapy. [Schol Ed] Front Biosci (Schol Ed) 2010; 2:515 - 26; http://dx.doi.org/10.2741/s82; PMID: 20036965
   PubMedGoogle Scholar
• Tong L, Harwood HJ Jr.. Acetyl-coenzyme A carboxylases: versatile targets for drug discovery. J Cell Biochem 2006; 99:1476 - 88; http://dx.doi.org/10.1002/jcb.21077; PMID: 16983687
   PubMed Web of Science ®Google Scholar
• Roongta UV, Pabalan JG, Wang X, Ryseck RP, Fargnoli J, Henley BJ, et al. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer Res 2011; 9:1551 - 61; http://dx.doi.org/10.1158/1541-7786.MCR-11-0126; PMID: 21954435
   PubMed Web of Science ®Google Scholar
• Kim SJ, Choi H, Park SS, Chang C, Kim E. Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation. Mol Cells 2011; 31:371 - 7; http://dx.doi.org/10.1007/s10059-011-0043-5; PMID: 21331774
   PubMed Web of Science ®Google Scholar
• Minville-Walz M, Pierre AS, Pichon L, Bellenger S, Fèvre C, Bellenger J, et al. Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells. PLoS One 2010; 5:e14363; http://dx.doi.org/10.1371/journal.pone.0014363; PMID: 21179554
   PubMedGoogle Scholar
• Igal RA. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 2010; 31:1509 - 15; http://dx.doi.org/10.1093/carcin/bgq131; PMID: 20595235
   PubMed Web of Science ®Google Scholar
• Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avancès C, et al. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther 2010; 9:1740 - 54; http://dx.doi.org/10.1158/1535-7163.MCT-09-1064; PMID: 20530718
   PubMed Web of Science ®Google Scholar
• Liu H, Liu JY, Wu X, Zhang JT. Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int J Biochem Mol Biol 2010; 1:69 - 89; PMID: 20706604
   PubMedGoogle Scholar
• Vainio P, Lehtinen L, Mirtti T, Hilvo M, Seppänen-Laakso T, Virtanen J, et al. Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins. Oncotarget 2011; 2:1176 - 90; PMID: 22202492
   PubMed Web of Science ®Google Scholar
• Bratos K, Roszak A, Cikowska-Woźniak E, Niecewicz P. [Analysis of epidemiologic risk factors for endometrial cancer]. Ginekol Pol 2002; 73:945 - 50; PMID: 12722379
   PubMedGoogle Scholar
• Gull B, Karlsson B, Milsom I, Granberg S. Factors associated with endometrial thickness and uterine size in a random sample of postmenopausal women. Am J Obstet Gynecol 2001; 185:386 - 91; http://dx.doi.org/10.1067/mob.2001.115869; PMID: 11518897
   PubMed Web of Science ®Google Scholar
• Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11:185 - 92; http://dx.doi.org/10.1023/A:1008946825313; PMID: 10710204
   PubMed Web of Science ®Google Scholar
• Shoff SM, Newcomb PA. Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol 1998; 148:234 - 40; http://dx.doi.org/10.1093/oxfordjournals.aje.a009630; PMID: 9690359
   PubMed Web of Science ®Google Scholar
• Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, et al. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 1997; 57:5077 - 85; PMID: 9371506
   PubMed Web of Science ®Google Scholar
• Chu K, Miyazaki M, Man WC, Ntambi JM. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation. Mol Cell Biol 2006; 26:6786 - 98; http://dx.doi.org/10.1128/MCB.00077-06; PMID: 16943421
   PubMed Web of Science ®Google Scholar
• Toth JI, Datta S, Athanikar JN, Freedman LP, Osborne TF. Selective coactivator interactions in gene activation by SREBP-1a and -1c. Mol Cell Biol 2004; 24:8288 - 300; http://dx.doi.org/10.1128/MCB.24.18.8288-8300.2004; PMID: 15340088
   PubMed Web of Science ®Google Scholar
• Amemiya-Kudo M, Shimano H, Yoshikawa T, Yahagi N, Hasty AH, Okazaki H, et al. Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene. J Biol Chem 2000; 275:31078 - 85; http://dx.doi.org/10.1074/jbc.M005353200; PMID: 10918064
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang W, Liang B, Casimiro MC, Whitaker-Menezes D, Wang M, et al. PPARgamma activation induces autophagy in breast cancer cells. Int J Biochem Cell Biol 2009; 41:2334 - 42; http://dx.doi.org/10.1016/j.biocel.2009.06.007; PMID: 19563910
   PubMed Web of Science ®Google Scholar